Immune Dysregulation, Polyendocrinopathy and Enteropathy X-Linked Syndrome with Neonatal Onset: A Case Report

Authors

  • Joana Costa Branco Department of Pediatrics. Unidade Local de Saúde Santa Maria. Lisbon. https://orcid.org/0000-0001-5689-2018
  • Margarida Cunha Neonatology Service. Department of Pediatrics. Unidade Local de Saúde Santa Maria. Lisbon. https://orcid.org/0000-0002-0090-2464
  • Ana Dias Curado Infectious Diseases and Immunodeficiencies Unit. Department of Pediatrics. Unidade Local de Saúde Santa Maria. Lisbon. https://orcid.org/0000-0002-1385-7359
  • Inês Girbal Neonatology Service. Department of Pediatrics. Unidade Local de Saúde Santa Maria. Lisbon.
  • Isabel Esteves Infectious Diseases and Immunodeficiencies Unit. Department of Pediatrics. Unidade Local de Saúde Santa Maria. Lisbon.
  • Sandra Valente Neonatology Service. Department of Pediatrics. Unidade Local de Saúde Santa Maria. Lisbon.

DOI:

https://doi.org/10.20344/amp.23795

Keywords:

Genetic Diseases, X-Linked/genetics, Immune System Diseases/congenital, Immune System Diseases/genetics, Infant, Newborn, Polyendocrinopathies, Autoimmune/genetics

Abstract

Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is a rare monogenic autoimmune disorder caused by mutations in the FOXP3 gene. It typically presents in early infancy with severe multisystem autoimmunity. We report the case of a male preterm infant, born at 30 weeks’ gestation, who developed enteropathy, eczema, eosinophilia, and transfusion-dependent cytopenias. Recurrent infections and a desquamative rash raised suspicion of an inborn error of immunity. Immunological studies revealed absent FOXP3 expression, and genetic testing confirmed a hemizygous pathogenic variant in FOXP3 (c.1076C>T), establishing the diagnosis. Immunosuppressive therapy with corticosteroids and sirolimus was initiated, and the patient was referred for hematopoietic stem cell transplantation. From the cases reported in the literature, this is the first neonatal onset case of IPEX reported in Portugal. This case highlights the importance of suspecting IPEX syndrome in infants with early-onset autoimmunity and immunodeficiency, enabling timely diagnosis and improved outcomes in this life-threatening condition.

Downloads

Download data is not yet available.

References

Powell BR, Buist NR, Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr. 1982;100:731-7.

Delmonte OM, Notarangelo LD. IPEX syndrome: from diagnosis to cure, learning along the way. J Allergy Clin Immunol. 2024;153:351-63.

Barzaghi F, Passerini L. IPEX syndrome: improved knowledge of immune pathogenesis empowers diagnosis. Front Pediatr. 2021;9:612760.

Park JH, Lee KH, Jeon B, Ochs HD, Lee JS, Gee HY, et al. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: a systematic review. Autoimmun Rev. 2020;19:102526.

Van der Vliet HJ, Nieuwenhuis EE. IPEX as a result of mutations in FOXP3. Clin Dev Immunol. 2007;2007:89017.

Downloads

Published

2026-02-23

How to Cite

1.
Costa Branco J, Cunha M, Dias Curado A, Girbal I, Esteves I, Valente S. Immune Dysregulation, Polyendocrinopathy and Enteropathy X-Linked Syndrome with Neonatal Onset: A Case Report. Acta Med Port [Internet]. 2026 Feb. 23 [cited 2026 Mar. 19];. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/23795

Issue

Section

Case Report